Assertio Holdings, Inc.

NASDAQ:ASRT

Drug Manufacturers - Specialty & Generic

Healthcare
$23.50 +0.04%

+$0.01 today

Market cap
$151.86M
Beta
0.53
P/E (TTM)
-4.2
EPS (TTM)
-$5.55
52W Low $8.61High $23.50

Volume 0.27M

Average 0.33M

ASRT Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Assertio Holdings, Inc.NASDAQ: ASRT

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares grows in line with its trailing trend

Q1 FY2026 weighted avg shares of 6.43M shares rose 0.9% year over year, in line with the +0.9% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.2% from the prior quarter. Over 3 fiscal years it compounded at +26.9% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +0.9% holds above the trailing-twelve-month pace of +0.9%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
6.43M+0.2% QoQ
Last fiscal yearDec 2025
6.4M+0.8% YoY
LTMMar 2026
6.42M+0.9% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+0.9%——
1 year+0.8%——
3-year CAGR+26.9%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
6.4M USD
Year-over-year change
+0.8%
4-year CAGR
+22.1%

Weighted Avg Shares vs competitors

How ASRT compares with its peers on the latest reported figures

  • ASRT's LTM Mar 2026 weighted avg shares of 6.42M shares is the lowest of the 10 companies compared; the peer median is 41.11M shares.
  • Its year-over-year change of +0.9% is the 9th highest of 10, against a peer median of +7.6%.
  • Over three fiscal years its annual growth of +26.9% compares with a peer median of +7.8%.
ASRT Competitors Peer median
Weighted Avg Shares for ASRT and competitors
Company Period LTM YoY 3-year CAGR
VXRTVaxart, Inc.LTM Mar 2026232.05M +14.5%-22.1%
TCRXTScan Therapeutics, Inc.LTM Mar 2026129.84M +7.6%+75.4%
PMVPPMV Pharmaceuticals, Inc.LTM Mar 202652.9M +2.4%+4.8%
INCRInterCure Ltd.LTM Jun 202550.36M +8.8%+7.8%
LUNGPulmonx CorporationLTM Mar 202641.11M +4.5%+3.1%
ACRVAcrivon Therapeutics, Inc. Common StockLTM Mar 202638.56M +2.3%+20.7%
XBITXBiotech Inc.LTM Mar 202630.49M +0.1%+0.1%
FBIOFortress Biotech, Inc.LTM Mar 202628.39M +34.1%+67.6%
NTRBNutriband Inc.LTM Apr 202611.9M +8.4%+11.2%
ASRTAssertio Holdings, Inc.LTM Mar 20266.42M +0.9%+26.9%
Peer median (excluding ASRT) 41.11M+7.6%+7.8%

Competitors are the stored peer set for ASRT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue111.01M156.23M152.07M124.96M118.71M
Cost of Revenue15.83M18.75M27.02M39.23M65.39M
Gross Profit95.18M137.49M125.05M85.73M53.33M
Gross Margin85.7%88.0%82.2%68.6%44.9%
Research & Development002.84M3.82M1.69M
Selling, General & Admin56.56M48.1M69.74M76.95M68.86M
Operating Expenses85.76M98.08M368.59M110.21M70.55M
Depreciation & Amortization29.11M33.4M28.23M25.83M30.01M
EBITDA38.78M90.17M53.17M5.15M3.14M
EBITDA Margin34.9%57.7%35.0%4.1%2.6%
Operating Income9.42M39.41M(243.54M)(24.48M)(17.22M)
Operating Margin8.5%25.2%-160.1%-19.6%-14.5%
Interest Income0003.22M2.67M
Interest Expense10.22M7.96M3.38M3.04M3.08M
Other Income / Expenses(9.98M)(8.24M)(10.52M)2.95M(12.72M)
Income Before Tax(553K)31.17M(254.05M)(21.53M)(29.94M)
Pre-Tax Margin-0.5%19.9%-167.1%-17.2%-25.2%
Income Tax Expense728K(78.46M)77.89M52K435K
Net Income(1.28M)109.63M(331.94M)(21.58M)(30.38M)
Net Margin-1.2%70.2%-218.3%-17.3%-25.6%
EPS (Basic)(0.45)34.95(70.05)(3.45)(4.74)
EPS (Diluted)(0.45)30.45(70.05)(3.45)(4.74)
Weighted Avg Shares2.88M3.13M4.74M6.35M6.4M
Weighted Avg Shares (Diluted)2.88M3.64M4.74M6.35M6.4M

Assertio Holdings, Inc.

NASDAQ:ASRT

Intrinsic Alpha fair value

Locked

Current Price

$23.50

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.